Valion Bio Gross Margin Growth & History (VBIO)

Valion Bio's gross margin was 0.26% for fiscal 2024.

View full Valion Bio company overview

Valion Bio annual gross margin history

Valion Bio annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20242024-12-310.26%−24.15 pp
20232023-12-3124.40%+8.15 pp
20222022-12-3116.25%+19.27 pp
20212021-12-31−3.02%

Valion Bio gross margin trends

Across the available reported history, Valion Bio's gross margin decreased from 24.40% to 0.26%, a change of −24.15 percentage points. The latest reported quarter, Q3 2025, shows −99.32%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Valion Bio filings at SEC.gov ↗